Following CE marking and FDA 510k clearance, CardioCel® is seeing
increasing adoption as the tissue of choice for the repair of congenital heart
deformities, more complex heart defects and heart valve repair procedures......
Mr Olivier Ghez.......
Could it be any clearer.
You are spot on Ralom, AHZ is on its way to becoming a whale.
Following CE marking and FDA 510k clearance, CardioCel® is...
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.91 |
Change
-0.090(0.50%) |
Mkt cap ! $344.2M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.75 | $74.32K | 4.151K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 681 | $17.90 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.25 | 100 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |